Tempus AI Building Multimodal Whole-Genome Dataset for AI Research

09:02 AM EDT, 09/11/2026 (MT Newswires) -- Tempus AI (TEM) said Friday it is building a research platform with 100,000 whole genome sequences paired with longitudinal clinical data to help researchers understand disease better and develop AI-enabled insights. The new dataset will be integrated into its existing de-identified multimodal platform to enable researchers to access genomic information alongside clinical histories, imaging, pathology and patient outcomes, the company said. Tempus said its long-term goal is to expand the dataset to reach 1 million genomes. The initial dataset is available through its Early Adopter Program, with general availability planned for mid-2027, the company said. Tempus AI shares were 1% higher in premarket activity Friday.